Announcing Our $15M Series A Fundraising to Continue Elevating Patient Care Everywhere
Evidently, a pioneering AI platform transforming healthcare workflows, announced today that it has raised $15M in Series A funding. DN Capital led the fundraising, with participation from FRAMEWORK, Clear Ventures, Fellows Fund, and existing investors.
Evidently addresses fundamental healthcare data problems that are worsening despite tremendous progress in digitization and interoperability. It acts as an AI resident, intelligently synthesizing information from disparate sources including external health records and faxes, and delivers concise, actionable summaries alongside real-time decision support. Evidently empowers clinicians to deliver exceptional care while reducing burnout and driving institutional success.
Evidently’s platform is already driving significant financial and efficiency gains at leading health systems across the US, reducing transplant referral chart prep time by over 90%, improving clients’ Case Mix Index accuracy while reducing queries, and enabling a post-acute care ACO to achieve a 1.4 point increase in Risk Adjustment Factor through harmonized data aggregation.
Feng Niu, CEO of Evidently commented, “Clinicians are still overwhelmed by fragmented data and the pressure to meet institutional goals. While ambient scribes are great, they are just the beginning. Imagine an AI resident that helps you code accurately, identify clinical trial candidates, and make more informed decisions at the point of care. By automating low-level cognitive tasks, we’re empowering healthcare providers to focus on what matters most—delivering exceptional care. With this funding, we can meet the growing demand for our platform and create a future where advanced technology is accessible to all healthcare providers.”
The funding will enable Evidently to meet the rapidly growing demand for its ‘EvidentlyOne’ product while advancing new solutions for population health and clinical research,driven by the expertise of Chief Product Officer Kalie Dove-Maguire, MD. As part of the investment, Gulsah Wilke, Partner at DN Capital, will join Evidently’s board of directors bringing extensive experience from her previous role as COO at ADA Health, where she helped scale a leading health technology company. She will provide valuable strategic insights to support Evidently’s growth.
Gulsah Wilke, Partner at DN Capital, said:
“Evidently is transforming healthcare by addressing one of its most critical challenges—unstructured data—and driving better outcomes for healthcare providers and patients. The platform is a vital tool for improving efficiency, reducing costs and providing returns for both providers and investors. We were impressed by Feng’s journey as a migrant founder and his proven track record of building and scaling successful AI-driven companies, combined with Kalie’s deep expertise at the intersection of healthcare and technology, they form a uniquely capable team. We are excited to help Evidently scale their business and bring their innovative platform to healthcare providers across the US.”
Evidently’s leadership team boasts a unique combination of expertise in machine learning, healthcare, and product development. CEO and Founder Feng Niu is an AI researcher-turned serial entrepreneur who previously co-founded Alation and Lattice Data—category leaders in managing enterprise and unstructured data—with Lattice Data being acquired by Apple for $200 million. Chief Product Officer Kalie Dove-Maguire, MD, brings a unique blend of clinical and product expertise, ensuring Evidently’s platform seamlessly integrates into healthcare workflows to address the most pressing challenges faced by providers.
Peter Misek, Managing Partner at FRAMEWORK, remarked:
“AI is a massive technological wave that has the opportunity to solve some of the world’s largest challenges. Healthcare is one such challenge and we believe Evidently’s Cognitive AI approach is a game-changer, setting itself apart from the other AI-powered tools in the ecosystem by taking a human-first approach to delivering measurable results for hospitals and health systems.”
Rajeev Madhavan, Partner at Clear Ventures, added:
“We are delighted to partner with Feng and the Evidently team from inception as their founding investor. What sets Evidently apart is their ability to give physicians back their most precious resource – time. By automating low-level cognitive tasks and surfacing critical insights from unstructured medical data, they’re not just improving hospital revenues, but fundamentally changing how clinical teams work! The company has been quickly deployed at many leading, innovative health systems, like the University of Iowa. Our continued investment reflects our confidence in their technology’s potential to scale and make a meaningful impact across the entire healthcare ecosystem.”
